259 related articles for article (PubMed ID: 29729422)
1. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
Caccamo A; Belfiore R; Oddo S
Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology.
Orr ME; Salinas A; Buffenstein R; Oddo S
Neurobiol Aging; 2014 Jun; 35(6):1233-42. PubMed ID: 24411482
[TBL] [Abstract][Full Text] [Related]
3. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.
Caccamo A; De Pinto V; Messina A; Branca C; Oddo S
J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720
[TBL] [Abstract][Full Text] [Related]
4. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism.
Caccamo A; Maldonado MA; Majumder S; Medina DX; Holbein W; Magrí A; Oddo S
J Biol Chem; 2011 Mar; 286(11):8924-32. PubMed ID: 21266573
[TBL] [Abstract][Full Text] [Related]
5. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.
Caccamo A; Majumder S; Richardson A; Strong R; Oddo S
J Biol Chem; 2010 Apr; 285(17):13107-20. PubMed ID: 20178983
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
[TBL] [Abstract][Full Text] [Related]
7. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
[TBL] [Abstract][Full Text] [Related]
8. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
9. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
[TBL] [Abstract][Full Text] [Related]
10. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
[TBL] [Abstract][Full Text] [Related]
12. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.
Stöhr O; Schilbach K; Moll L; Hettich MM; Freude S; Wunderlich FT; Ernst M; Zemva J; Brüning JC; Krone W; Udelhoven M; Schubert M
Age (Dordr); 2013 Feb; 35(1):83-101. PubMed ID: 22057897
[TBL] [Abstract][Full Text] [Related]
14. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
15. mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.
Di Domenico F; Tramutola A; Foppoli C; Head E; Perluigi M; Butterfield DA
Free Radic Biol Med; 2018 Jan; 114():94-101. PubMed ID: 28807816
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.
Ma T; Hoeffer CA; Capetillo-Zarate E; Yu F; Wong H; Lin MT; Tampellini D; Klann E; Blitzer RD; Gouras GK
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862226
[TBL] [Abstract][Full Text] [Related]
17. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
18. FTO is involved in Alzheimer's disease by targeting TSC1-mTOR-Tau signaling.
Li H; Ren Y; Mao K; Hua F; Yang Y; Wei N; Yue C; Li D; Zhang H
Biochem Biophys Res Commun; 2018 Mar; 498(1):234-239. PubMed ID: 29501742
[TBL] [Abstract][Full Text] [Related]
19. The db mutation improves memory in younger mice in a model of Alzheimer's disease.
Zhang L; Fernandez-Kim SO; Beckett TL; Niedowicz DM; Kohler K; Dasuri K; Bruce-Keller AJ; Murphy MP; Keller JN
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2157-2167. PubMed ID: 31034991
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
Chen J; Long Z; Li Y; Luo M; Luo S; He G
Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
